MedPath
FDA Approval

Tobramycin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 19, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tobramycin(3 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

NuCare Pharmaceuticals,Inc.

NuCare Pharmaceuticals,Inc.

010632300

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tobramycin

Product Details

NDC Product Code
68071-4537
Application Number
ANDA207444
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
February 19, 2021
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACT
BORIC ACIDInactive
Code: R57ZHV85D4Class: IACT
SODIUM SULFATE ANHYDROUSInactive
Code: 36KCS0R750Class: IACT
TYLOXAPOLInactive
Code: Y27PUL9H56Class: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCFClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: VZ8RRZ51VKClass: ACTIBQuantity: 3 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath